"S2-3 STRATEGIC PROPOSALS TO AVOID TOXIC DRUG INTERACTIONS DURING NEW DRUG DEVELOPMENT : MOLECULAR TOXICOLOGY PROPOSALS (<SYMPOSIUM 2>Strategy how we can learn drug-drug interaction during the development of a new drug)
スポンサーリンク
概要
- 論文の詳細を見る
- 日本トキシコロジー学会の論文
- 1996-12-20
著者
-
Yokoi T
Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine
-
Yokoi Tsuyoshi
北海道大学 薬研究 代謝分析
-
Fujita K
Graduate School Of Science Osaka City University
-
FUJITA Ken-ichi
Division of Drug Metabolism and Molecular Toxicology, Faculty of Pharmaceutical Sciences, Tohoku Uni
-
KAMATAKI Tetsuya
Division of Drug Metabolism, Faculty of Pharmaceuti-cal Sciences, Hokkaido University
-
Fujita Ken-ichi
Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University
-
Fujita Ken-ichi
Lab.drug Metab. Grad.sch.pharm.sci. Hokkaido Univ.
-
Fujita K
Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University
-
NAKAMURA Katsunori
Department of Clinical Pharmacology, Graduate School of Medicine, Gunma University
-
Kamataki T
Hokkaido Univ. Sapporo Jpn
-
Kamataki Tetsuya
Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University
-
YOKOI Tsuyoshi
Division of Analytical Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University
-
YAMAYOSHI Yasuko
Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University
-
NAKAMURA Katsunori
Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University
-
KUSHIDA Hirotaka
Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University
-
MITSUHASHI Harumi
Rhone-Poulenc Rorer Japan Inc.
-
UENO Takeshi
Rhone-Poulenc Rorer Japan Inc.
-
Nakayama K
Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University
-
Kamataki Tetsuya
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University
-
Kushida Hirotaka
Medicinal Evaluation Laboratory Tsumura & Co.
-
Fujita Ken-ichi
Div Drug Metab. Pharm.sci. Hokkaido Univ.
-
Fujita Ken-ichi
Division Of Drug Metabolism And Molecular Toxicology Faculty Of Pharmaceutical Sciences Tohoku Unive
-
Kamataki Tetsuya
Lab.drug Metab. Grad.sch.pharm.sci. Hokkaido Univ.
-
Tsumita Yuki
Department Of Medicine And Clinical Science Gunma University Graduate School Of Medicine
-
Yokoi Tsuyoshi
Division Of Drug Metabolism And Toxicology Faculty Of Pharmaceutical Sciences Kanazawa University
-
Yokoi Tsuyoshi
Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci
-
Nakayama Kazuo
Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci
-
Yokoi T
Laboratory Of Drug Metabolism Graduate School Of Pharmaceutical Sciences Hokkaido University
-
Yokoi Tsuyoshi
Division Of Analytical Biochemistry Faculty Of Pharmaceutical Sciences Hokkaido University:explorato
-
Yokoi Tsuyoshi
Fac.pharm. Sci. Hokkaido Univ.
-
Nakayama Katsuo
Department Of Clinical Pharmacology Graduate School Of Medicine Gunma University
-
Nakamura Katsunori
Department Of Clinical Pharmacology Graduate School Of Medicine Gunma University
-
Kamataki Tetsuya
Laboratory Of Drug Metabolism Division Of Pharmacobio-dynamics Graduate School Of Pharmaceutical Sci
-
Yamayoshi Yasuko
Division Of Drug Metabolism Faculty Of Pharmaceutical Sciences Hokkaido University
-
Yokoi Tsuyoshi
Div.drug Metab. Fac.of Pharm.sic. Hokkaido Univ.
-
Kamataki Tetsuya
Div.drug Metab. Fac.of Pharm.sic. Hokkaido Univ.
-
Kamataki Tetsuya
Lab. Drug Metab. Fac. Pharm. Sci. Hokkaido University
-
Kamataki Tetsuya
Laboratory of Drug Metabolism, Hokkaido University Graduate School of Pharmaceutical Sciences
-
Kushida Hirotaka
Medicinal Evaluation Laboratory, Tsumura & Co.
関連論文
- MACROMOLECULAR BINDING OF CARCINOGENIC/MUTAGENIC N- HYDROXYARYLAMINES THROUGH O-ACETYLATION PATHWAY
- MECHANISM OF MUTATION AND METABOLIC ACTIVATION OF NITRO-, NITROSO-, HYDROXYLAMINO-COMPOUNDS IN NITRO-COMPOUNDS RESISTANT MUTANTS OF AMES TESTAR STRAIN (TA98NR, TA98/1,8-DNP_6)
- Two Novel Single Nucleotide Polymorphisms (SNPs) of the FMO3 Gene in Japanese
- A Mutation in the Flavin-containing Monooxygenase 3 Gene and its Effects on Catalytic Activity for N-oxidation of Trimethylamine In Vitro
- Overexpression of CYP2A6 in human colorectal tumors
- O11-01 Induction of Human CYP1A1 by 2-Phenyl-benzotriazoles(PBTAs)which Are Metabolically Activated by CYP1A1
- O-18 Role of Human N-Acetyltransferase in the Metabolic Activation of 2-Phenylbenzotriazole (PBTA) Derivatives.(Proceedings of the 27th Annual Meeting)
- 21C-01-1 Metabolic Activation of PBTA-1 and PBTA-2 by Human Cytochrome P450 1A1.
- Molecular Cloning and Characterization of Rat ST1B1 and Human ST1B2 cDNAs, Encoding Thyroid Hormone Sulfotransferases
- Establishment of in silico systems to predict the effects of genetic polymorphism on the enzymatic activity of cytochrome P450
- Enzymatic Characterization of Human Cytosolic Sulfotransferases : Identification of ST1B2 as a Thyroid Hormone Sulfotransferase
- Bacterial Expression and Functional Characterization of a Rat Thyroid Hormone Sulfotransferase, ST1B1
- Molecular Cloning, Expression, and Enzymatic Characterization of Rabbit Hydroxysteroid Sulfotransferase AST-RB2 (ST2A8)^1
- ROLE OF GROWTH HORMONE ON THE EXPRESSION OF SEX-SPECIFIC FORMS OF CYTOCHROME P-450,P-450-MALE AND P-450-FEMALE
- STUDIES ON SEX-SPECIFIC FORMS OF CYTOCHROME P-450 IN MALE AND FEMALE RATS
- Inhibitory Effects of Nicardipine to Cytochrome P450 (CYP) in Human Liver Microsomes(Biopharmacy)
- Co-operative Regulation of the Transcription of Human Dihydrodiol Dehydrogenase(DD)4/Aldo-Keot Reductase(AKR)1C4 Gene by Hepatocyte Nuclear Factor(HNF)-4α/γand HNF-1α.
- Characterization of a Novel Variant (S145C/L311V) of 3α-Hydroxysteroid/Dihydrodiol Dehydrogenase in Human Liver.
- CHARACTERIZATION OF TRANSGENIC MICE CARRYING A HUMAN FETUS-SPECIFIC CYP3A7.
- Expression and Characterization of Dog CYP2D15 Using Baculovirus Expression System^1
- Inhibiton by EGCG of benzo[a]pyrene-induced mutations in the lung of HITEC mice.
- CYP2A6 gene deletion reduces oral cancer risk in betel quid chewers.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
- 2B-08 Establishment of Genetically Engineered E.coli Highly Sensitive to Nitrosamines by Introducing Human CYP2E1
- CYP3A5 Contributes Significantly to CYP3A-mediated Drug Oxidations in Liver Microsomes from Japanese Subjects
- プロポフォール薬物動態と心拍出量
- Isolation of an Acremonium sp. Capable of Liquefying Cross-Linked Poly(γ-Glutamic Acid) Hydrogels and the Fungal Enzyme Involved in the Disruption of γ-Ray Irradiation-Mediated Cross-Linking(MISCELLANEOUS)
- Flocculating Activity of Cross-linked Poly-γ-Glutamic Acid against Bentonite and Escherichia coli Suspension Pretreated with FeCl_3 and Its Interaction with Fe^(ENVIRONMENTAL BIOTECHNOLOGY)
- TOXICOLOGICAL SIGNIFICANCE OF A FORM OF CYTOCHROME P-450 HIGHLY PURIFIED FROM LIVER MICROSOMES OF PCBTREATED RATS : CATALYTIC AND IMMUNOCHEMICAL EXAMINATIONS OF A HIGH SPIN FORM OF CYTOCHROME P-448
- Application of Primary Hepatocytes from p53-Knockout Mice for Studies of Expression of Cyp3a
- Expression of human CYP1A2 capable of activating heterocyclic amine in Bm 6 cells using baculovirus (BmNPV) system.
- In vivo Evaluation of Coumarin and Nicotine as Probe Drugs to Predict the Metabolic Capacity of CYP2A6 Due to Genetic Polymorphism in Thais
- Novel Nonsynonymous Polymorphisms of the CYP1A1 Gene in Japanese
- Toxicological roles of human and rodent CYP2As in the mutagenic activation of N-nitrosamines.(GENERAL SESSION BY ORAL PRESENTATION)(DRUG METABOLISM)
- Novel Mutations of the CYP2A6 Gene in a Thai Population with Lowered Capacity of Coumarin 7-Hydroxylation
- O11-15 Mutagenic activation of tobacco-related N-nitrosamines by rat CYP2As in comparison with human CYP2A6.
- O11-14 Comparison of the toxicolqical roles of mouse CYP2A with human CYP2A6.
- Genetic Polymorphism in the 5'-Flanking Region of Human CYP1A2 Gene : Effect on the CYP1A2 Inducibility in Humans
- METABOLIC ACTIVATION OF AFLATOXIN B_1 BY HUMAN PLACENTAL MICROSOMES
- Formation of an Antibacterial Metabolite from a New Macrolide Compound 23-O-Benzyl-5-mycaminosyl-tylonolide (TMC-101), by a Hepatic Microsomal Drug-Metabolizing Enzyme System
- 5-2) MOLECULAR TOXICOLOGY ON CYTOCHROME P-450 IN HUMAN FETAL LIVERS
- Immunochemical Studies for the Presence of P-450 HFLa, a Form of Cytochrome P-450 in Human Fetal Livers in Human Hepatocellular Carcinoma Cells
- SPECIES DIFFERENCE OF CYTOCHROME (S) P-450 CROSS-REACTIVE WITH ANTI-P-450-MALE ANTIBODIES
- Large-scale Production of Genetically Engineered CYP3A4 in E. coli: Application of a Jarfermenter
- 21C-04-1 Inhibition of the Activity of Human Cytochrome P450 Involved in the Metabolic Activation of Procarcinogens by Green Tea Catechins.
- Establishment of Salmonella Tester Strains Co-expressing Cytochrome P450 and NADPH-cytochrome P450 Reductase.
- Application of Genetically Engineered Bacteria Carrying Human Cytochrome P450 to Toxicological Studies
- Metabolic Activation of Dimethylnitrosamine(DMN) by Human CYP2E1 Expressed in O^6-Methylguanine-DNA Methyltransferase-Deficient Cells
- Establishment Of A Salmonella Tester Strain Ultra-Sensitive To Mutagenic Heterocyclic Amines
- DEVELOPMENT OF PRACTICAL METHODS WHICH MIMIC DRUG METABOLISM IN HUMANS.
- EXPRESSION OF RECOMBINANT HUMAN CYTOCHROME P450 (P450 OR CYP) 2A6 IN ESCHERICHIA COLI.
- "S2-3 STRATEGIC PROPOSALS TO AVOID TOXIC DRUG INTERACTIONS DURING NEW DRUG DEVELOPMENT : MOLECULAR TOXICOLOGY PROPOSALS (Strategy how we can learn drug-drug interaction during the development of a new drug)
- Stable expression of CYP3A4 and CYP3A7, adult and fetal-specific forms of cytochrome P450 in human liver, in CHL cells and its application to toxicological testing.
- Effects of NO-1886 (Ibrolipim), a Lipoprotein Lipase-Promoting Agent, on Gene Induction of Cytochrome P450s, Carboxylesterases, and Sulfotransferases in Primary Cultures of Human Hepatocytes
- Detection of Three Genetic Polymorphisms in the 5'-Flanking Region and Intron 1 of Human CYP1A2 in the Japanese Population
- Homologous Unequal Cross-Over within the Human CYP2A Gene Cluster as a Mechanism for the Deletion of the Entire CYP2A6 Gene Associated with the Poor Metabolizer Phenotype
- Thiopurine Methyltransferase Genotype and Phenotype Status in Japanese Patients with Systemic Lupus Erythematosus(Biopharmacy)
- Comparison of the efficacy of an oral calcitriol pulse or intravenous 22-oxacalcitriol therapies in chronic hemodialysis patients
- Sulfite is Generated from PAPS by Activated Neutrophils
- Extremely high levels of C-reactive protein in patients with acute lupus serositis
- 221 INTRODUCTION OF CYTOCHROME P-450 cDNAS INTO CULTURED MAMMALIAN CELLS AND THEIR APPLICATION TO IN VITRO TOXICOLOGICAL STUDIES
- Identification of Phoslactomycin E as a Metabolite Inducing Hyphal Morphological Abnormalities in Aspergillus fumigatus IFO 5840
- Amplification of Vacuole-targeting Fungicidal Activity of Antibacterial Antibiotic Polymyxin B by Allicin, an Allyl Sulfur Compound from Garlic
- Synergistic Fungicidal Activities of Amphotericin B and N-Methyl-N"-dodecylguanidine : A Constituent of Polyol Macrolide Antibiotic Niphimycin
- Inhibitory Activity of 1-Farnesylpyridinium on the Spatial Control over the Assembly of Cell Wall Polysaccharides in Schizosaccharomyces pombe
- P-502 Structure-Activity Relationship Studies on UK-2A, A Novel Antifungal Antibiotic from Streptomyces sp. 517-02
- P-368 Identification of Phoslactomycin E as a Metabolite Inducing Hyphal Morphological Abnormalities of Aspergillus fumigatus IFO 5840
- Involvement of Oxidative Stress Induction in Na^+ Toxicity and Its Relation to the Inhibition of a Ca^-Dependent but Calcineurin-Independent Mechanism in Saccharomyces cerevisiae(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
- Biosynthesis of Poly-γ-Glutamic Acid in Plants : Transient Expression of Poly-γ-Glutamate Synthetase Complex in Tobacco Leaves(PLANT BIOTECHNOLOGY)
- Proposals for Wastewater Treatment by Applying Flocculating Activity of Cross-linked Poly-γ-Glutamic Acid(Environmental Biotechnology)
- Physicochemical Properties of Cross-linked Poly-γ-Glutamic Acid and Its Flocculating Activity against Kaolin Suspension (Environmental Biotechnology)
- Oxidative Stress-Dependent Inhibition of Yeast Cell Growth by Farnesylamine and Its Possible Relation to Amine Oxidase in the Mitochondrial Fraction(MICROBIAL PHYSIOLOGY AND BIOTECHNOLOGY)
- UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 : VI (3). Role of Substituents on Dilactone Ring of UK-2A and Antimycin A_3 against Generation of Reactive Oxygen Species in Porcine Renal Proximal Tubule LLC-PK_1 Cells
- Growth Inhibition Dependent on Reactive Oxygen Species Generated by C9-UK-2A, a Derivative of the Antifungal Antibiotic UK-2A, in Saccharomyces cerevisiae
- UK-2A,B,C, and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VIII. Reactive Oxygen Species Generated by C9-UK-2A, a Derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001
- UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VI.(2). Structure-activity Relationships of UK-2A
- UK-2A, B, C, and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 : VII. Membrane Injury Induced by C9-UK-2A, a Derivative of UK-2A, in Rhodotorula mucilaginosa IFO 0001
- L-2,5-Dihydrophenylalanine, an Inducer of Cathepsin-dependent Apoptosis in Human Promyelocytic Leukemia Cells(HL-60)
- Antifungal Activity of Radicicol against Mucor flavus IFO 9560
- Genotyping of Thiopurine Methyltransferase Using Pyrosequencing^(Biopharmacy)
- Studies on the Interactions between Drug and Estrogen. II. On the Inhibitory Effect of 29 Drugs Reported to Induce Gynecomastia on the Oxidation of Estradiol at C-2 or C-17
- Role of cyclosporin A in remitting nephrotic syndrome in a Japanese patient infected with human immunodeficiency virus type 1
- Acute Myeloid Leukemia Accompanied by Multiple Thrombophlebitis
- Preventive Effects of Hange-shashin-to on Irinotecan Hydrochloride-Caused Diarrhea and Its Relevance to the Colonic Prostaglandin E_2 and Water Absorption in the Rat
- Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT-11), in Rats
- Metabolism of Selegiline Hydrochloride, a Selective Monoamine B-type Inhibitor, in Human Liver Microsomes
- UK-2A, B, C and D, Novel Antifungal Antibiotics from Streptomyces sp. 517-02 VI(1). Structure-Activity Relationship of UK-2A
- Determination of Isepamicin in Human Plasma by HPLC with Fluorescence Detection after Derivatization Using 6-Aminoquinolyl-N-hydroxysuccinimidyl-carbamate(Analytical Biochemistry)
- A novel intronic mutation that may affect genotyping result of CYP2C8 by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) is strongly associated with CYP2C8^*3 in a South American population
- Time-Dependent Induction of Midazolam-1-hydroxylation Enzymes in Rats Treated with St. John's Wort(Biopharmacy)
- OCCURRENCE OF AUTOANTIBODY TO PROTEIN DISULFIDE ISOMERASE IN PATIENTS WITH HEPATIC DISORDER
- OCCURRENCE OF AUTOANTIBODY TO PROTEIN DISULFIDE ISOMERASE IN RATS WITH XENOBIOTIC-INDUCED HEPATITIS
- Relevance of Irinotecan Hydrochloride-Induced Diarrhea to the Level of Prostaglandin E_2 and Water Absorption of Large Intestine in Rats
- Aplastic anemia associated with initiation of nizatidine therapy in a hemodialysis patient
- MOLECULAR CLONING OF MOUSE LIVER FLAVIN CONTAINING MONOOXYGENASE (FMO1) cDNA AND CHARACTERIZATION OF THE EXPRESSION PRODUCT : METABOLISM OF THE NEUROTOXIN, 1,2,3,4- TETRAHYDROISOQUINOLINE (TIQ)
- Induction of Human CYP1A2 and CYP3A4 in Primary Culture of Hepatocytes from Chimeric Mice with Humanized Liver
- HIGH SUSCEPTIBILITY TO AFLATOXIN B_1 AND BENZO[A]PYRENE OF BALB3T3 A31-1-1 CELLS EXPRESSING MONKEY CYP1A1
- LOW ACTIVITY OF ALDEHYDE DEHYDROGENASE (ALDH) IN LIVER OF SUNCUS MURlNUS : POSSIBLE EXPLANATION FOR HIGH SENSITIVITY TO ALCOHOL
- Evaluation of Human CYP1A2 and CYP3A4 mRNA Expression in Hepatocytes from Chimeric Mice with Humanized Liver
- A Major Genotype in UDP-glucuronosyltransferase 2B15
- Tissue-specific mRNA Expression Profiles of Human Nuclear Receptor Subfamilies